FDA Refuses Application for New mRNA Flu Vaccine, Moderna Says

(MedPage Today) — The FDA is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday.
The news is the latest sign of the FDA’s heightened scrutiny of vaccines…